Third Harmonic Bio News Today

SAN FRANCISCO, May 28, 2024 -- Third Harmonic Bio, Inc. , a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (NASDAQ:THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the

Third Harmonic Bio (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…

U.S. IND filed for THB335 with anticipated clinical trial start during 2Q’24 Strong financial position with cash and cash equivalents totaling $269.1 million as of December 31, 2023 SAN...

Third Harmonic Bio, Inc. (NASDAQ: THRD) shares cleared breakeven Tuesday, as the biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today reported financial results for the fourth quarter ended December ...

NEW YORK, Feb. 22, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Third Harmonic Bio, Inc. on behalf of the companys shareholders.  The investigation seeks to...

/PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Third Harmonic Bio, Inc. (NASDAQ: THRD) on behalf of the companys shareholders. The...

By Dean Seal Third Harmonic Bio has hired a former group vice president at Horizon Therapeutics to be its next chief financial officer. The biopharmaceutical...